128 related articles for article (PubMed ID: 16792920)
21. [Idiopathic splenomegalic myelofibrosis. Report of 2 clinical cases].
Grandis P
Ann Osp Maria Vittoria Torino; 1983; 26(7-12):293-308. PubMed ID: 6680005
[TBL] [Abstract][Full Text] [Related]
22. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
Kvasnicka HM; Thiele J
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
[TBL] [Abstract][Full Text] [Related]
23. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis.
Vener C; Fracchiolla NS; Gianelli U; Calori R; Radaelli F; Iurlo A; Caberlon S; Gerli G; Boiocchi L; Deliliers GL
Blood; 2008 Feb; 111(4):1862-5. PubMed ID: 18029552
[TBL] [Abstract][Full Text] [Related]
26. Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining.
Ponzoni M; Savage DG; Ferreri AJ; Pruneri G; Viale G; Servida P; Bertolini F; Orazi A
Mod Pathol; 2004 Dec; 17(12):1513-20. PubMed ID: 15272276
[TBL] [Abstract][Full Text] [Related]
27. Chronic idiopathic myelofibrosis terminating in extramedullary anaplastic plasmacytoma.
Liu ML; Kallakury B; Kessler C; Hartmann DP; Azumi N; Ozdemirli M
Leuk Lymphoma; 2006 Feb; 47(2):315-22. PubMed ID: 16321864
[TBL] [Abstract][Full Text] [Related]
28. Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis.
Ahmed A; Chang CC
Arch Pathol Lab Med; 2006 Aug; 130(8):1133-43. PubMed ID: 16879014
[TBL] [Abstract][Full Text] [Related]
29. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
30. Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor.
Steurer M; Zoller H; Augustin F; Fong D; Heiss S; Strasser-Weippl K; Gastl G; Tzankov A
Hum Pathol; 2007 Jul; 38(7):1057-1064. PubMed ID: 17442379
[TBL] [Abstract][Full Text] [Related]
31. [Primary myelofibrosis: description of a series of 53 patients].
Pereira A; Cervantes F; Montserrat E; Rozman C
Med Clin (Barc); 1989 Apr; 92(14):521-5. PubMed ID: 2666765
[TBL] [Abstract][Full Text] [Related]
32. Analysis of risk factors of the evolution of myelofibrosis in pre-fibrotic chronic idiopathic myelofibrosis: a retrospective study based on follow up biopsies of 70 patients by using the RECPAM method.
Kreft A; Wiese B; Weiss M; Choritz H; Buhr T; Büsche G; Georgii A
Leuk Lymphoma; 2004 Mar; 45(3):553-9. PubMed ID: 15160918
[TBL] [Abstract][Full Text] [Related]
33. [Chronic idiopathic myelofibrosis. Study of 36 patients and review of the literature].
Celada A
Sangre (Barc); 1983; 28(4):401-20. PubMed ID: 6658634
[No Abstract] [Full Text] [Related]
34. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
[TBL] [Abstract][Full Text] [Related]
35. [Idiopathic myelofibrosis].
Saad GM; de Almeida TV
Rev Paul Med; 1991; 109(2):47-50. PubMed ID: 1887177
[TBL] [Abstract][Full Text] [Related]
36. [Primary myelofibrosis in an infant--a case report and review of the literature].
Hatae Y; Ohkoshi Y; Ueno M; Nakadate H; Iizuka S; Takeda T
Rinsho Ketsueki; 1993 Sep; 34(9):1039-43. PubMed ID: 8230748
[TBL] [Abstract][Full Text] [Related]
37. Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the janus kinase 2 (JAK2) gene.
Mark HF; Sotomayor EA; Nelson M; Chaves F; Sanger WG; Kaleem Z; Caughron SK
Exp Mol Pathol; 2006 Dec; 81(3):217-23. PubMed ID: 16959246
[TBL] [Abstract][Full Text] [Related]
38. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
Kvasnicka HM; Thiele J
Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
[TBL] [Abstract][Full Text] [Related]
39. European consensus on grading bone marrow fibrosis and assessment of cellularity.
Thiele J; Kvasnicka HM; Facchetti F; Franco V; van der Walt J; Orazi A
Haematologica; 2005 Aug; 90(8):1128-32. PubMed ID: 16079113
[TBL] [Abstract][Full Text] [Related]
40. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
